Other Information
+Added: On May 30, 2019, we appointed Mr.
+Added: Krisztian Toth as our Director and Chairman.
+Added: On June 6, 2019, we appointed Mr.
+Added: Ken Kessler as our Director.
+Added: Also on June 6, 2019, we accepted the resignation of Dr.
+Added: Patrick Frankham as Director.
Exhibit Number
25 unchanged sentences
(filed on June 17, 2015 with our Annual Report on Form 10K/A)
+Added: Exhibit Number
Material Contracts
56 unchanged sentences
10% Senior Secured Convertible Debenture (CDN$1,750,000) due March 2, 2019 (CD-4) (incorporated by reference to our Current report on Form 8-K filed on November 6, 2018)
+Added: 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-3)
+Added: 10% Senior Secured Convertible Debentures (CDN$1,375,000) due June 1, 2019 (CD-4)
Rule 13a-14(d)/15d-14(d) Certifications
17 unchanged sentences
PIVOT PHARMACEUTICALS INC.
−Removed: December 18, 2018
+Added: June 17, 2019
/s/ Patrick Frankham
2 unchanged sentences
(Principal Executive Officer)
−Removed: December 18, 2018
+Added: June 17, 2019
/s/ Moira Ong
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.